Navigation Links
Regulatory Affairs Professionals Society (RAPS) Honors 2009 RAPS Fellows
Date:9/14/2009

PHILADELPHIA, Sept. 14 /PRNewswire-USNewswire/ -- The Regulatory Affairs Professionals Society (RAPS) today honored the 2009 class of RAPS Fellows. The 16 Fellows are highly accomplished professionals working in the healthcare product regulatory field. They were honored during the opening session of the 2009 RAPS Annual Conference & Exhibition in Philadelphia.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070314/DCW091LOGO )

The RAPS Fellows program recognizes senior regulatory professionals for their continued significant contributions and leadership in the advancement of the profession and the professional. Fellows receive a dignified status and special services from RAPS and will serve as important resources for strategic dialogue, mentoring, implementation of special initiatives and international development. This is the second year of the RAPS Fellows program.

The 2009 RAPS Fellows are:

  • Chas Burr, MS, MBA, graduate program director, Health Product Regulation, Regis College; and president and principal consultant, Chas Burr Q/R Services Inc.
  • Joy Cavagnaro, Ph.D., DABT, RAC, president and founder, Access BIO
  • Nancy Chew, MS, RAC, president, Regulatory Affairs, North America Inc.
  • Michael Hamrell, Ph.D., RAC, president, MORIAH Consultants
  • Marie D. Kuker, RPh, RAC, president, Kuker Regulatory Consulting LLC
  • Philip T. Lavin, Ph.D., executive chairman, Averion International
  • Kenneth F. Miles, Ph.D., RAC, principal consultant, Miles Technologies Group LLC
  • Penny Northcutt, RAC, CQA, president and CEO, REGSolutions LLC
  • Peggy Pence, Ph.D., RAC, president and executive officer, Symbion Research International Inc.
  • Kathryn Rangus, MS, MBA, RAC, president, Drug & Device Regulatory Services Inc.
  • Robert Schiff, MS, PhD, RAC, CQA, president and CEO, Schiff & Company Inc.
  • David C. Steinberg, MBA, president, Steinberg & Associates Inc.
  • Susan Stewart, RAC, vice president, regulatory affairs, TransMolecular Inc.
  • O. Reed Tarwater, Ph.D., RAC, director, pharmaceutical consulting services, Anson Group
  • Henrietta Ukwu, MD, FACP, vice president, global regulatory affairs, Wyeth Pharmaceuticals
  • Pamela Williamson, MBA, RAC, senior vice president, global regulatory affairs and corporate quality, Genzyme Corporation

Members of the working media who wish to cover all or part of the 2009 RAPS Annual Conference & Exhibition should send an email to RAPS Communications Manager Zachary Brousseau at zbrousseau@raps.org or may register on site by going to the press office in room 104A of the Pennsylvania Convention Center. Media must bring valid press credentials or a letter from an assigning editor on company letterhead.

Conference sponsors include: Anson Group, Boston Scientific, BSI Healthcare, Crimson/Transperfect, Elsevier Business Intelligence, GE Healthcare, Kendle, Prolifiq Software, Stericycle and Tarius.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the rapidly growing medical device, pharmaceutical and biotechnology sectors. Regulatory professionals play vital roles in making better healthcare products possible. They work throughout the healthcare product lifecycle, ensuring these products are safe and effective, while driving organizational strategy and sound decision-making. RAPS supports these individuals and the regulatory profession by providing education and training, Regulatory Affairs Certification (RAC), professional standards, research, knowledge-sharing, publications, networking, career development opportunities and other valuable resources; and is committed to helping its members continually develop the knowledge and skills they need to excel. RAPS is headquartered near Washington, DC, with offices in Brussels and Tokyo. RAPS.org


'/>"/>
SOURCE Regulatory Affairs Professionals Society (RAPS)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RAPS Honors Dexter, Shorer and Novales-Li for Outstanding Contributions to Healthcare Product Regulatory Profession
2. Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism
3. Key Stakeholders to Discuss Regulatory Issues Related to the Use of Study Endpoints in Multinational Clinical Trials
4. Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North America
5. Validation & Compliance Institute, LLC, to Provide Medical Device Regulatory Training for the University of Michigans Medical Innovation Center
6. CSCs FirstDoc Recognized by EMC as a Preferred Regulatory Compliance Application for Life Sciences Industry
7. Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product
8. NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs
9. Saint Vincent Health Center Ensures Regulatory Compliance with SIS
10. Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)
11. LCA Applauds Senate Leadership Team Working to Secure New FDA Regulatory Authority Over Tobacco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... ... Philpart, senior director at PolicyLink, will be the keynote speaker at its second ... and Men of Color Framework, which develops comprehensive strategies to create and expand ...
(Date:2/21/2017)... ... February 21, 2017 , ... Support of value-based care ... the secure exchange of data across industry solutions, Fogo Data Centers announces the launch ... community. A healthy community is one in which all systems work well, work ...
(Date:2/21/2017)... ... February 21, 2017 , ... HIMSS is ... connected care demonstration spanned multiple health information systems including OpenEMR, EMRDirect, and ... providers have no Health Information Exchange outside of faxing. Medal’s innovative technology “meets ...
(Date:2/20/2017)... ... February 20, 2017 , ... A new digital ... are called back for additional examinations without sacrificing cancer detection, according to a ... the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for use ...
(Date:2/20/2017)... ... February 20, 2017 , ... Scrubbing in for his first ... Dr. Christopher Pezzi remembers the excitement of the surgeon training him. , “He was ... to do this? Don’t tell anyone, but I would do it for free,’” Dr. ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Feb. 21, 2017  International Isotopes Inc. (OTCQB: INIS) ... placement with certain investors for approximately $3.4 million of ... Series C Convertible Redeemable Preferred Stock (the "Series C ... annual rate of 6% and is convertible into common ... use the proceeds for operating capital, to pay off ...
(Date:2/21/2017)... , Feb. 21, 2017 Research and Markets ... Devices - Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a ...
(Date:2/21/2017)... 21, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Uterine cancer Drugs Price Analysis and Strategies ... cancer market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Uterine cancer ...
Breaking Medicine Technology: